- Gainers: Salarius Pharmaceuticals (NASDAQ:SLRX) +14%. Castle Biosciences (NASDAQ:CSTL) +10%. Checkpoint Therapeutics (NASDAQ:CKPT) +9%. Plus Therapeutics (NASDAQ:PSTV) +9%. Caladrius Biosciences (NASDAQ:CLBS) +8%.
- Losers: Clearside Biomedical (NASDAQ:CLSD) -45%. Avinger (NASDAQ:AVGR) -34%. Retrophin (NASDAQ:RTRX) -26%. Mustang Bio (NASDAQ:MBIO) -12%. Principia Biopharma (NASDAQ:PRNB) -11%.